Our forward-looking solution provides seamless integration with any drug safety system, in addition to out-of-the-box public data sources, while delivering a systematic approach for the management of risks, from early detection to communication.
Springfield, NJ (PRWEB) June 14, 2013
Medsight Solutions, a provider of cloud and enterprise-based software for the life sciences industry, will showcase its integrated risk management solution at the DIA 2013 49th Annual Meeting in Boston.
The advanced software solution, called Medsight Sapphire, will streamline existing pharmacovigilance (PV) practices and help life sciences companies manage benefit-risk lifecycle of medicinal products. Based on industry best practices and regulatory guidelines, Medsight Sapphire is the only industry solution to offer end-to-end risk management, starting from development to post-authorization. It helps organizations comply with the latest (PV) legislation in Europe, while addressing the core business requirements of signal detection and management, benefit-risk evaluation and safety communication.
“In the end, pharmacovigilance is all about ensuring patient safety by defining, managing and effectively communicating the benefit-risk balance of medicinal products” said Sharad Prakash, president of Medsight Solutions. “Our forward-looking solution provides seamless integration with any drug safety system, in addition to out-of-the-box public data sources, while delivering a systematic approach for the management of risks, from early detection to communication.”
Medsight Solutions will occupy booth #1832 at DIA 2013 49th Annual Meeting, and will provide short demos and presentations on its product.
“We are thrilled to showcase our integrated risk management solution at DIA 2013, as we are truly on the cutting edge of giving the life sciences industry the framework it needs to aggregate data, detect potential safety issues, evaluate impact and communicate the changing benefit-risk balance of products,” said Prakash.
DIA is an annual life sciences industry event that includes more than 250 educational offerings, 450 exhibitors, 800 speakers and 7,000 attendees. The event features life sciences professionals across a wide range of disciplines, sharing their work in the discovery, development and life cycle management of a wide range of medical products. DIA’s overall goal is to facilitate the innovation needed to create safe and effective medical products and services to patients across the globe.
The DIA 2013 49th Annual Meeting will take place June 23-27 at the Boston Convention and Exhibition Center.
About Medsight Solutions:
Medsight Solutions offers cloud and enterprise-based solutions for the benefit-risk assessment, drug safety intelligence, regulatory reporting and compliance monitoring processes of life sciences companies. The company’s advanced platform combines industry best practices with innovative technologies, delivering results critical to business competitiveness in a regulatory-compliant environment. Medsight Sapphire is the only industry solution that offers end-to-end risk management life cycle for the medicinal products, from development to post-marketing. Founded in 2011, Medsight Solutions has offices in Springfield, N.J. and Bangalore, India. For more information, visit http://www.medsight.com.